Massive typhoid vaccine trial shows promise in High-Risk indian city
⭐️ VACCINE ⭐️
Completed
This study tested a typhoid vaccine called TyphiBEV in over 72,000 people aged 1 to 30 in Vellore, India, a city with high typhoid rates. Researchers compared typhoid cases in vaccinated groups versus unvaccinated groups to see if the vaccine reduces infections. The goal is to un…
Phase: PHASE4 • Sponsor: Christian Medical College, Vellore, India • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC